Wednesday, July 8, 2026

pharma · Peripheral Artery Disease · Muscle-Invasive Bladder Carcinoma

Blackmores Institute

Blackmores Institute clinical programs — 0 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

20 Jubilee Ave, Warriewood, New South Wales 2102, AU HQ
2012 Founded
27 Employees
TGA registrant Type
Company details
Status
Public
HQ
20 Jubilee Ave, Warriewood, New South Wales 2102, AU
Founded
2012
Employees
27
Programs
17
Drugs
24
Patents
38
Intelligence · Clinical Programs

Blackmores Institute projects

0 ClinicalTrials.gov programs sponsored by Blackmores Institute.

Blackmores Institute has 0 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

No programs matched

Try a different phase filter or check back as we index more trials.

Frequently asked questions

How many clinical projects does Blackmores Institute have?

0 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.